Abstract

BackgroundCoronary computed tomography angiography (CCTA) is widely used as a first-line noninvasive modality that frequently exhibits no or nonobstructive coronary artery disease (CAD) in clinical practice, along with abnormal left ventricular (LV) geometry on echocardiography. However, the combined prognostic value of these findings has not been well elucidated. Therefore, we aimed to evaluate the prognostic implications of abnormal LV geometry in individuals with no or nonobstructive CAD.MethodsA total of 5806 subjects with no CAD or nonobstructive CAD (luminal narrowing < 50%) on CCTA were included in the study. The major exclusion criteria were structural heart disease and a history of myocardial infarction or coronary revascularization. Abnormal LV geometry on echocardiography was defined as LV mass index > 95 g/m2 in women and > 115 g/m2 in men, and/or relative wall thickness > 0.42. The primary outcome was all-cause mortality.ResultsA total of 5803 subjects without significant obstructive CAD (age, 56.6 ± 8.87 years; men, 3884 [66.9%]). Of them, 4045 (69.7%) subjects had normal LV geometry and 1758 (30.3%) had abnormal LV geometry respectively. During a mean follow-up of 6.2 ± 1.48 years, 84 (1.44%) subjects died in the study population. Of these, 56 subjects were from the normal LV geometry group (1.24%) and 28 were from the abnormal LV geometry group (2.32%). Subjects with abnormal LV geometry had significantly worse survival rates (log-rank, p < 0.001). After adjustment for confounding factors, abnormal LV geometry was an independent predictor of all-cause mortality (adjusted hazard ratio, 1.64; 95% confidence interval, 1.04–2.58; p = 0.034). Moreover, abnormal LV geometry was significantly worse in survival when classified as those with no CAD (log-rank, p = 0.024) and nonobstructive CAD (Log-rank, p < 0.001).ConclusionsAbnormal LV geometry portends a worse prognosis in subjects with no or nonobstructive CAD. These findings suggest that LV geometry assessment can help improve the stratification of individuals with these CCTA findings.

Highlights

  • Coronary computed tomography angiography (CCTA) is widely used as a first-line noninvasive modal‐ ity that frequently exhibits no or nonobstructive coronary artery disease (CAD) in clinical practice, along with abnor‐ mal left ventricular (LV) geometry on echocardiography

  • This study evaluated the prognostic value of abnormal LV geometry estimated by echocardiography in individuals with no or nonobstructive CAD on CCTA

  • The prognostic importance of nonobstructive CAD has been underappreciated, several studies have recently shown that nonobstructive CAD confirmed by CCTA is associated with increased mortality risk in various populations [3, 4, 8]

Read more

Summary

Introduction

Coronary computed tomography angiography (CCTA) is widely used as a first-line noninvasive modal‐ ity that frequently exhibits no or nonobstructive coronary artery disease (CAD) in clinical practice, along with abnor‐ mal left ventricular (LV) geometry on echocardiography. The emergence of coronary computed tomography angiography (CCTA) as a noninvasive imaging modality has made it possible to diagnose coronary artery disease (CAD) with excellent sensitivity (90–95%) and negative predictive value (93%–98%) [1]. The CCTA-based assessment of plaque size and its composition has recently gained particular attention as an imaging method to improve risk stratification and further statin allocation since this technique seems to enable the risk prediction of cardiovascular disease events in patients with nonobstructive CAD [7]. Due to technical challenges in the analysis of plaque characteristics, it has not become a part of real-world clinical practice, suggesting the need for more readily available tests on a routine clinical basis

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call